This paper is in the following e-collection/theme issue:
RCTs - Protocols/Proposals (non-eHealth) (311)Published on in Vol 5, No 4 (2016): Oct-Dec
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
Authors of this article:
Nobuko Yamaguchi1 ; Sonoko Misawa2 ; Yasunori Sato3 ; Kengo Nagashima3 ; Kanako Katayama1 ; Yukari Sekiguchi2 ; Yuta Iwai2 ; Hiroshi Amino2 ; Tomoki Suichi2 ; Takanori Yokota4 ; Yoichiro Nishida4 ; Nobuo Kohara5 ; Koichi Hirata6 ; Kazutoshi Nishiyama7 ; Ichiro Yabe8 ; Ken-Ichi Kaida9 ; Norihiro Suzuki10 ; Hiroyuki Nodera11 ; Shoji Tsuji12 ; Haruki Koike13 ; Jun-Ichi Kira14 ; Hideki Hanaoka1 ; Susumu Kusunoki15 ; Satoshi Kuwabara2 ; JET-GBS Group4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15
There are currently no tweets available for this article within the specified range.